Standard
Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve : Insights From Bench Testing to 25 Years. / Sathananthan, Janarthanan; Landes, Uri; Flaction, Lionel; Humair, Arnaud; Delaloye, Stéphane; Toggweiler, Stefan; Søndergaard, Lars; Wood, David A.; Webb, John G.
I:
JACC: Cardiovascular Interventions, Bind 14, Nr. 5, 2021, s. 586-588.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Sathananthan, J, Landes, U, Flaction, L, Humair, A, Delaloye, S, Toggweiler, S
, Søndergaard, L, Wood, DA & Webb, JG 2021, '
Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years',
JACC: Cardiovascular Interventions, bind 14, nr. 5, s. 586-588.
https://doi.org/10.1016/j.jcin.2020.10.030APA
Sathananthan, J., Landes, U., Flaction, L., Humair, A., Delaloye, S., Toggweiler, S.
, Søndergaard, L., Wood, D. A., & Webb, J. G. (2021).
Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years.
JACC: Cardiovascular Interventions,
14(5), 586-588.
https://doi.org/10.1016/j.jcin.2020.10.030Vancouver
Sathananthan J, Landes U, Flaction L, Humair A, Delaloye S, Toggweiler S o.a.
Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years.
JACC: Cardiovascular Interventions. 2021;14(5):586-588.
https://doi.org/10.1016/j.jcin.2020.10.030Author
Sathananthan, Janarthanan ; Landes, Uri ; Flaction, Lionel ; Humair, Arnaud ; Delaloye, Stéphane ; Toggweiler, Stefan ; Søndergaard, Lars ; Wood, David A. ; Webb, John G. / Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve : Insights From Bench Testing to 25 Years. I: JACC: Cardiovascular Interventions. 2021 ; Bind 14, Nr. 5. s. 586-588.
Bibtex
@article{2fdca470fb65488c86c49f79437cad23,
title = "Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years",
author = "Janarthanan Sathananthan and Uri Landes and Lionel Flaction and Arnaud Humair and St{\'e}phane Delaloye and Stefan Toggweiler and Lars S{\o}ndergaard and Wood, {David A.} and Webb, {John G.}",
note = "Funding Information: This study was a purely bench study with no human or animal participants, and ethics approval was not required. No patient data were used in this study. Dr. Sathananthan is a consultant to Edwards Lifesciences and Medtronic. Dr. Toggweiler is a consultant and proctor for Boston Scientific and NVT GmbH; and has received an institutional research grant from Boston Scientific. Dr. Sondergaard has received consultant fees and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Symetis. Dr. Wood is a consultant to and has received research funding from Edwards Lifesciences and Abbott. Dr. Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2021",
doi = "10.1016/j.jcin.2020.10.030",
language = "English",
volume = "14",
pages = "586--588",
journal = "J A C C: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier",
number = "5",
}
RIS
TY - JOUR
T1 - Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve
T2 - Insights From Bench Testing to 25 Years
AU - Sathananthan, Janarthanan
AU - Landes, Uri
AU - Flaction, Lionel
AU - Humair, Arnaud
AU - Delaloye, Stéphane
AU - Toggweiler, Stefan
AU - Søndergaard, Lars
AU - Wood, David A.
AU - Webb, John G.
N1 - Funding Information:
This study was a purely bench study with no human or animal participants, and ethics approval was not required. No patient data were used in this study. Dr. Sathananthan is a consultant to Edwards Lifesciences and Medtronic. Dr. Toggweiler is a consultant and proctor for Boston Scientific and NVT GmbH; and has received an institutional research grant from Boston Scientific. Dr. Sondergaard has received consultant fees and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Symetis. Dr. Wood is a consultant to and has received research funding from Edwards Lifesciences and Abbott. Dr. Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2021
Y1 - 2021
U2 - 10.1016/j.jcin.2020.10.030
DO - 10.1016/j.jcin.2020.10.030
M3 - Letter
C2 - 33663791
AN - SCOPUS:85101108613
VL - 14
SP - 586
EP - 588
JO - J A C C: Cardiovascular Interventions
JF - J A C C: Cardiovascular Interventions
SN - 1936-8798
IS - 5
ER -
